The predictive value of a positive phase 2 ASH abstract for peer-reviewed publication and progression to phase 3.

Cucchi, David G J; Polak, Tobias B; Ossenkoppele, Gert J; Rowe, Jacob M; Estey, Elihu H

Cucchi, David G J; Polak, Tobias B; Ossenkoppele, Gert J; Rowe, Jacob M; Estey, Elihu H.

Afiliação

Cucchi DGJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Polak TB; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Ossenkoppele GJ; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Rowe JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Estey EH; Shaare Zedek Medical Center, Jerusalem, Israel; and.

Blood ; 139(12): 1920-1923, 2022 03 24.

Article em En | MEDLINE | ID: mdl-35020824

Assuntos

Editoração; Sociedades Médicas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Editoração / Sociedades Médicas Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google